19
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Apoptosis Inducing Novel Anti-Leukemic Agent, Bis(4,7-Dimethyl-1,10 Phenanthroline) Sulfatooxovanadium(IV)[VO(SO4)(Me2-Phen)2] Depolarizes Mitochondrial Membranes

, &
Pages 625-634 | Received 09 Sep 2000, Published online: 01 Jul 2009
 

Abstract

Bis(4,7-dimethyl-1,10 phenanthroline) sulfatooxovanadium(IV) [VO(SO4)(Me2-Phen)2] induces apoptosis in human NALM-6 leukemia cells. In the present report, we demonstrate that VO(SO4)(Me2-Phen)2-induced apoptosis is mediated through the generation of reactive oxygen species (ROS), depletion of glutathione and depolarization of mitochondrial membrane potential (Δ±m). Using multilaser flow cytometry methods, we further mapped out the death sequence that occurs in VO(SO4)(Me2-Phen)2-treated leukemic cells. Triple labeling method to measure ROS, Δ±m and glutathione coupled with multilaser excitation flow cytometry showed that induction of ROS took place before the loss of mitochondrial permeability transition and depletion of glutathione. Correlated two parameter plots of glutathione content versus Δ±m showed that loss of Δ±m and depletion of glutathione closely follows each other. Translocation of phosphatidylserine to the outer leaflet of the cell membrane was the final step in the process before the cells became apoptotic. These results demonstrate that the mitochondrial permeability transition takes place during VO(SO4)(Me2-Phen)2-induced apoptosis and is mediated through induction of ROS and depletion of glutathione.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.